Novartis Sees Eye Syringe Patent Fail In Europe
A European appeals panel has refused to revive Novartis' patent for a syringe that delivers eye medicine, ruling that the company's blueprint for the device extends beyond the contents of its...To view the full article, register now.
Already a subscriber? Click here to view full article